posted by user: bplcse || 1068 views || tracked by 1 users: [display]

TCPIAIA 2024 : Targeted Chemotherapy with Personalized Immunotherapy: An AI Approach


When N/A
Where N/A
Submission Deadline Nov 20, 2023
Final Version Due Dec 20, 2023
Categories    therapies   chemotherapy   artificial intelligence   treatments

Call For Papers

Researchers are working hard to develop methods that will aid in deciding which therapies are the most successful since they have discovered that, for certain patients, the best results may be reached by combining precisely targeted chemotherapy with personalized immunotherapy. As a result of this discovery, researchers are attempting to devise strategies that will assist in establishing which treatments are the most effective. When lung cancer is detected at an early stage, patients who are candidates for surgery alone have a cure rate that ranges between sixty and seventy percent. Researchers are attempting to improve the percentage of patients who are cured by surgical procedures by combining them with other treatment modalities.
Following surgical intervention, patients are now eligible to pursue immunotherapy as well as treatment targeted at the specific cancer. These medications work to aid the body in destroying any cancer cells that may still be present after treatment. Others may benefit from a combination of chemotherapy and immunotherapy, which may help reduce the size of a tumor and make it possible for patients to undertake more sophisticated surgical procedures without as much risk. In the years to come, treatment for cancer will focus on. There have been significant leaps forward in terms of the treatment of cancer over the course of the last 20 years. We now have a far better understanding of how our cells interact with one another, how cancer suppresses and hides from the immune system, and how to support the body in reacting to stop the spread of cancer; nevertheless, there is still a great deal more to learn in this field.
Instead of treating patients with medications that are detrimental to the body as a whole, researchers are now aiming to identify the molecules that play an essential part in the communication that takes place between cells. This study, if it proves fruitful, might help pave the way for the development of novel immunotherapies that provide the body with assistance in its fight against cancer. In order to accurately plan cancer treatment, participation from a number of different members of the healthcare team is essential. Our cancer experts are able to determine the most effective treatment timeline and approach when they work together to uncover mutations that can be targeted with immunotherapy and discover mutations that can be targeted with immunotherapy.

Prasanalakshmi Balaji
College of Computer Science,
King Khalid University,
Abha, Kingdom of Saudi Arabia.

Dr.Abhishek Kumar
Department of CSE,
Chandigarh University,
Punjab, India.

Dr.Prasenjit Das
Department of CSE,
Chandigarh University,
Punjab, India.

Mr.Chetan Sharma
UpGrad Campus
Bengaluru, India.

Dr.Jade H.Y.Chen
Zhejiang University, China.

Related Resources

Ei/Scopus-AACIP 2024   2024 2nd Asia Conference on Algorithms, Computing and Image Processing (AACIP 2024)-EI Compendex
XXVII GA 2024   27th Generative Art International Annual Conference
IEEE-Ei/Scopus-ACEPE 2024   2024 IEEE Asia Conference on Advances in Electrical and Power Engineering (ACEPE 2024) -Ei Compendex
AAAI 2025   The 39th Annual AAAI Conference on Artificial Intelligence
CCVPR 2024   2024 International Joint Conference on Computer Vision and Pattern Recognition (CCVPR 2024)
EAIH 2024   Explainable AI for Health
IEEE-Ei/Scopus-SGGEA 2024   2024 Asia Conference on Smart Grid, Green Energy and Applications (SGGEA 2024) -EI Compendex
ITNG 2024   The 21st Int'l Conf. on Information Technology: New Generations ITNG 2024
BPMDS 2024   Business Process Modeling, Development, and Support
NeurIPS 2024   The Thirty-Eighth Annual Conference on Neural Information Processing Systems